CTRI Number |
CTRI/2020/02/023425 [Registered on: 18/02/2020] Trial Registered Prospectively |
Last Modified On: |
26/06/2021 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda |
Study Design |
Single Arm Study |
Public Title of Study
|
Management of Female Infertility - Endometrium Factor |
Scientific Title of Study
Modification(s)
|
Management of Vandhyatva (Female infertility W.S.R.to Endometrium thickness)by an ayurvedic treatment protocol- A single arm open labelled clinical trial |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Jalpa Rupareliya |
Designation |
2nd year PG scholar Department of Prasuti Tantra Evam Streeroga |
Affiliation |
IPGT & RA Gujarat Ayurved University, jamnagar |
Address |
IPGT & RA Gujarat Ayurved University near GG Hospital Jamnagar
5th floor department of Prasuti Tantra Evam Streeroga New building IPGT & RA GAU Jamnagar- 361008
Gujarat
India
Jamnagar GUJARAT 361008 India |
Phone |
9765396906 |
Fax |
|
Email |
jalparupareliya20@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Prof Shilpa Donga |
Designation |
Associate Professor Department of Prasuti Tantra Evam Streeroga |
Affiliation |
IPGT & RA Gujarat Ayurved University, jamnagar |
Address |
IPGT & RA Gujarat Ayurved University near GG Hospital Jamnagar
5th floor department of Prasuti Tantra Evam Streeroga new building IPGT & RA GAU Jamnagar- 361008
Gujarat
India
Jamnagar GUJARAT 361008 India |
Phone |
9825646796 |
Fax |
|
Email |
drshilpadonga@yahoo.com |
|
Details of Contact Person Public Query
|
Name |
Prof LP Dei |
Designation |
HOD department of Prasuti Tantra evam streeroga |
Affiliation |
IPGT & RA Gujarat Ayurved University, jamnagar |
Address |
IPGT & RA Gujarat Ayurved University near GG Hospital Jamnagar
5th floor Department of Prasuti Tantra Evam Streeroga New building IPGT & RA GAU Jamnagar- 361008
Gujarat
India
Jamnagar GUJARAT 361008 India |
Phone |
9228198366 |
Fax |
|
Email |
Deilaxmipriya@yahoo.com |
|
Source of Monetary or Material Support
|
Institute for Post Graduate Teaching And Research in Ayurveda Gujarat Ayurved University near GG Hopsital Jamnagar |
|
Primary Sponsor
|
Name |
Institute for Post Graduate Teaching And Research in Ayurveda Gujarat Ayurved University |
Address |
Institute for Post Graduate Teaching & Research in Ayurveda
Gujarat Ayurved University near GG hospital
jamnagar 361008 |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Jalpa D Rupareliya |
Institute for Post Graduate Teaching & Research in Ayurveda Gujarat Ayurved University |
Department of Prasutitantra Evam Streeroga 5th floor new building Room no- 503 Jamnagar GUJARAT |
9765396906
jalparupareliya20@gmail.com |
|
Details of Ethics Committee
Modification(s)
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committee Institute for Post Graduate teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: N972||Female infertility of uterine origin, |
|
Intervention / Comparator Agent
Modification(s)
|
Type |
Name |
Details |
Comparator Agent |
not applicable |
not applicable |
Intervention |
Yonipeechu and oral drug |
Saubhagyanandana Ghrita Yonipeechu (for 6 days, for 1 cycle) along with Jivaniya Choorna orally for 30 days. |
|
Inclusion Criteria
|
Age From |
20.00 Year(s) |
Age To |
40.00 Year(s) |
Gender |
Female |
Details |
1. Female having active marital life of 1 year.
2. Female patients having primary and secondary both type of infertility with endometrial thickness of 7 mm diagnosed by TVS, irrespective of its cause.
4. Female patients indicated for Yogabasti and Uttarabasti.
|
|
ExclusionCriteria |
Details |
1. Female patients having age less than 20 years and more than 40 years.
2. Female patients having infertility due to bilateral tubal blockage.
3. Carcinoma of reproductive tract.
4. Active inflammatory disease, eg. -Acute PID, STD like HIV, VDRL, HBsAG, HCV.
5. Congenital anomaly of reproductive tract.
6. Uncontrolled systemic disease like Diabetes, Hypertension.
7. Female patients contraindicatedfor Yogabasti and Uttarabasti.
|
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Open Label |
Primary Outcome
Modification(s)
|
Outcome |
TimePoints |
To evaluate effect of Yonipeechu and oral drug in the management of Vandhyatva (female infertility) w.s.r.to endometrium thickness. |
30 days |
|
Secondary Outcome
Modification(s)
|
Outcome |
TimePoints |
To evaluate efficacy of Yonipeechu and oral drug in the associate complains of menstrual abnormalities, like oligomenorrhoea, dysmenorrhoea, etc. |
30 days |
|
Target Sample Size
Modification(s)
|
Total Sample Size="10" Sample Size from India="10"
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="15" |
Phase of Trial
|
Phase 1/ Phase 2 |
Date of First Enrollment (India)
|
21/02/2020 |
Date of Study Completion (India) |
03/04/2021 |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
Modification(s)
|
No |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
Modification(s)
|
Purpose of Study Endometrium plays a major role in establishing a pregnancy and any alteration in this, could be a potential cause for failure of implantation thus affecting fertility. Endometrial factor is an important subset in infertility among women, Other treatments like, In-Vitro Fertilization (IVF) - Embryo Transfer (ET), Gamete Intra Fallopian Transfer (GIFT) etc are also available. But all these treatments require a healthy endometrium which is capable of implantation of embryo in mother’s womb.It is becoming clear that overcoming the current bottleneck in improvements to assisted reproductive techniques will require a closer look at the interface between uterus and embryo. Indeed, embryo implantation requires a cross talk with a receptive endometrium.Extended oestrogen treatment and adjuvant therapy, such as low dose aspirin, vaginal Sildenafil etc. are used in modern science for improving endometrium thickness but there isn’t any proved incidence for this treatment.There are many drawbacks in available modern treatment protocols, like unsatisfactory results, highly expensive and lots of side effects, frequent abortion, multiple gestations and major long term possibility of endometrial cancer.So, there is a great scope of research to find out safe, potent, less costly and effective remedies from Ayurveda classics for the management of Vandhyatva w.s.r. to Endometrial thickness. Here an effort in this direction has been put forward by this research work.Hypothesis of Study : Null Hypothesis: (H0): Saubhagyanandana
Ghrita Yonipeechu and Jeevaniya Churna
orally is not effective in the management of Vandhyatva (female
infertility) w.s.r to endometrium thickness?
Alternative Hypothesis (H1) :Saubhagyanandana
Ghrita Yonipeechu and Jeevaniya Churna
orally is effective in the management of Vandhyatva (female infertility)
w.s.r to endometrium thickness? Plan of study: (1) Review of Literature (2) Pharmacognostical study (3) Pharmaceutical study (4) Clinical study Clinical study DIAGNOSTIC CRITERIA: Female patients having endometrial thickness £ 7 mm on TVS findings (up to 14th day of menstrual cycle) will be included for the study. INCLUSION CRITERIA: 1. Females of child bearing age of 20 to 40 years. 2. Female having active marital life of 1 year. 3. Female patients having primary and secondary both type of infertility with endometrial thickness£ 7 mm diagnosed by TVS, irrespective of its cause. EXCLUSION CRITERIA: 1. Female patients having age less than 20 years and more than 40 years. 2. Female patients having infertility due to bilateral tubal blockage. 3. Carcinoma of reproductive tract. 4. Active inflammatory disease, eg. -Acute PID, STD like HIV, VDRL, HBsAG, HCV. 5. Congenital anomaly of reproductive tract. 6. Uncontrolled systemic disease like Diabetes, Hypertension. Investigations: 1. General investigations Hematological Examination- Hb% , T.L.C., D.L.C., E.S.R.,PCV [BT,AT] Biochemical Examination: FBS. [BT,AT] Urine Examination: Routine and Microscopic examination. [BT,AT] Serological Examination- HIV, HBsAg, VDRL, HCV[BT] Pregnancy test – if required. 2. Special Investigation: Transvaginal Ultrasonography (B.T, A.T.) - To see the Appel Baums Uterine Scoring Pattern.
TREATMENT PROTOCOL:
Enrolled patients fulfilling the criteria will be given following treatment.
DRUG
|
DOSE
|
ROUTE
|
DURATION
|
Saubhagyanandana
Ghrita
|
3-5ml
once daily for 6 days
|
Intravaginal
|
1
cycle
|
Jeevaniya
Churna
|
6
gm BD
|
Orally
with Anupana of Milk
|
30
days
|
PATHYA-APATHYAPathya (do) and Apathya (don’ts) will be advised to the patients as per Prakriti, Kala etc. WITHDRAWAL CRITERIA Patient will be withdrawal from the study if any serious complication developed which requires urgent treatment during the study. FOLLOW UP After the completion of treatment, follow up study will be done for 1 month with the interval of 15 days. CRITERIA OF ASSESSMENT:
SUBJECTIVE PARAMETER: Subjective Parameter will be assessed where effect will be seen on the basis of changes at end point in comparison to base line score.It includes following parameters: | Before treatment | After treatment | Follow Up | Regularity | Regular/Irregular | Regular/Irregular | Regular/Irregular | Quantity | Scanty/Moderate/ Excessive | Scanty/Moderate/ Excessive | Scanty/Moderate/ Excessive | Duration | | | | Interval | | | | Painful/painless: | | | | Character of flow | clots/watery/ foul smelling | clots/watery/ foul smelling | clots/watery/ foul smelling | 2. OBJECTIVE PARAMETER: The assessment will be done on the basis of the Appelbaum’s Uterine Scoring System for Reproduction ("USSR") by Trans Vaginal Sonography by color Doppler. It includes following parameters:
- Endometrial Thickness (mm)
- Endometrial layering
- Myometrial Echogenicity
- Uterine artery Doppler flow (PI)
- Endometrial blood flow in zone 3
- Myometrial blood flow (Gray scale)
|